By Tim Schwab
As the National Research Council (NRC) sets out on an 18-month, “science-based” study into the safety, benefits and drawbacks of GMOs, it will be interesting to see which science—and which scientists—the NRC will be consulting.
The initial indications aren’t great. While the NRC boasts that it is aiming to “provide an independent, objective assessment of what has been learned since GE crops were introduced,” several of the scientific experts it has selected to direct the new report have substantial ties to industry—and are clearly in a position to advocate on behalf of biotech companies.
The reason this matters is because the biotech industry has long had an outsized role in shaping the science surrounding GMOs, with tactics including funding and authoring countless studies, censoring or restricting independent research and attacking unfavorable findings. The result of this influence is a body of scientific literature with substantial industry bias and major gaps—especially in safety research. Industry also uses its unparalleled financial resources to bulldoze the public debate on GMOs, including spending hundreds of millions of dollars lobbying Congress. Do biotech companies really need another platform to advocate their pro-GMO stance? Read the full article…